Laurus Labs
Laurus Labs Limited, commonly referred to as Laurus Labs, is a prominent player in the pharmaceutical industry, headquartered in Hyderabad, India. Founded in 2005, the company has established itself as a leader in the development and manufacturing of active pharmaceutical ingredients (APIs), generic formulations, and contract research services. With a strong focus on high-quality production, Laurus Labs offers a diverse portfolio that includes antiretroviral, oncology, and cardiovascular products, setting itself apart through its commitment to innovation and regulatory compliance. The company has achieved significant milestones, including multiple approvals from global regulatory authorities, which solidify its market position. Recognised for its robust research and development capabilities, Laurus Labs continues to expand its operational footprint across various regions, contributing to its reputation as a trusted partner in the pharmaceutical sector.
DitchCarbon Score
How does Laurus Labs's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Laurus Labs's score of 26 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Laurus Labs's reported carbon emissions
In 2024, Laurus Labs reported total carbon emissions of approximately 198,782,000 kg CO2e for Scope 1, 176,678,000 kg CO2e for Scope 2, and 87,212,000 kg CO2e for Scope 3 emissions. This reflects a slight increase in emissions compared to 2023, where emissions were about 182,215,000 kg CO2e for Scope 1, 159,094,000 kg CO2e for Scope 2, and 73,322,000 kg CO2e for Scope 3. Laurus Labs has committed to near-term climate targets, although specific reduction targets have not been disclosed. The company is actively engaged in monitoring and reporting its emissions across all three scopes, demonstrating transparency in its climate commitments. As a player in the Pharmaceuticals, Biotechnology, and Life Sciences sector, Laurus Labs is positioned to contribute to industry-wide efforts to reduce greenhouse gas emissions. The company has not yet committed to a net-zero target, but it continues to evaluate its climate strategy in alignment with global sustainability goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 182,215,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 159,094,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 73,322,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Laurus Labs is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
